AAA
Affinity Asset Advisors Portfolio holdings
AUM
$676M
This Quarter Return
-1.45%
1 Year Return
+29.75%
3 Year Return
+452.89%
5 Year Return
–
10 Year Return
–
AUM
$635M
AUM Growth
+$635M
(+3.2%)
Cap. Flow
+$13M
Cap. Flow
% of AUM
2.04%
Top 10 Holdings %
Top 10 Hldgs %
39.19%
Holding
115
New
23
Increased
29
Reduced
18
Closed
15
Top Buys
| 1 |
Alkermes
ALKS
|
$13.9M |
| 2 |
CLYM
Climb Bio, Inc. Common Stock
CLYM
|
$11.9M |
| 3 |
Apogee Therapeutics
APGE
|
$9.61M |
| 4 |
Arcellx
ACLX
|
$8.83M |
| 5 |
Insmed
INSM
|
$8.38M |
Top Sells
| 1 |
Apellis Pharmaceuticals
APLS
|
$9.7M |
| 2 |
Absci
ABSI
|
$5.82M |
| 3 |
Cytokinetics
CYTK
|
$5.61M |
| 4 |
Fulcrum Therapeutics
FULC
|
$5.2M |
| 5 |
Axsome Therapeutics
AXSM
|
$4.81M |
Sector Composition
| 1 | Healthcare | 89.38% |
| 2 | Financials | 0.8% |
